SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-012700
Filing Date
2021-09-23
Accepted
2021-09-23 16:25:32
Documents
12
Period of Report
2021-09-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20210922x8k.htm   iXBRL 8-K 32085
  Complete submission text file 0001558370-21-012700.txt   149564

Data Files

Seq Description Document Type Size
2 EX-101.SCH imgn-20210922.xsd EX-101.SCH 2984
3 EX-101.LAB imgn-20210922_lab.xml EX-101.LAB 16753
4 EX-101.PRE imgn-20210922_pre.xml EX-101.PRE 9900
5 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20210922x8k_htm.xml XML 4648
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 211272803
SIC: 2834 Pharmaceutical Preparations